Evaluation of Current Synthetic Mesh Materials in Pelvic Organ Prolapse Repair
- First Online:
- 257 Downloads
With increasing use of synthetic material in pelvic organ prolapse repair, the reporting and incidence of associated complications also have increased. The role of synthetic mesh in pelvic organ prolapse repair remains controversial and it is a therapeutic dilemma whether to continue its use in patients with poor native tissues, despite the recent public safety notification provided by the U.S. Food and Drug Administration. In this article, we review the biomaterials used in pelvic organ prolapse repair and discuss the outcomes and associated complications, paying emphasis to the benefits and the risks.
KeywordsPelvic organ prolapse Cystocele Rectocele Mesh Sacrocolpopexy Female urology
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 4.U.S. Census Bureau. U.S. Interim Projections by age, sex, race, and hispanic origin:2000–2050. Available at: http://www.census.gov/ipc/www/usinterimproj/. Accessed January 2011.
- 16.Maher C, Feiner B, Baessler K, Adams EJ, Hagen S, Glazener CM. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2010;CD004014.Google Scholar
- 19.•• Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C, Nordic Transvaginal Mesh Group. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364:1826–36. This is a randomized controlled study comparing outcomes of mesh use and standard pelvic organ prolapse repair.PubMedCrossRefGoogle Scholar
- 22.Carey M, Higgs P, Goh J, Lim J, Leong A, Krause H, Cornish A. Vaginal repair with mesh versus colporrhaphy for prolapse: a randomised controlled trial. BJOG. 116:1380–6.Google Scholar
- 30.Moore RD, Miklos JR. Vaginal repair of cystocele with anterior wall mesh via transobturator route: efficacy and complications with up to 3-year follow-up. Adv Urol. 2009;743831.Google Scholar
- 37.The Haute Autorite’ de Sante’ (HAS). Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_implant_prolapse_voie_vaginale.pdf. Accessed January 2011.
- 38.Food and Drug Administration. FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. Available at http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm262435.htm. Accessed March 2012.
- 39.Murphy M, Holzberg A, van Raalte H, Kohli N, Goldman HB, Lucente V, Pelvic Surgeons Network. Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: “UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse.”. Int Urogynecol J. 2012;23:5–9.PubMedCrossRefGoogle Scholar